CONSILIUM CARE
DEAD

Serial Number

79299543

Owner

mobile Health AG

Filing Date

Sep 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CONSILIUM CARE Trademark

Serial Number: 79299543

CONSILIUM CARE is a trademark filed by mobile Health AG on September 29, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

mobile Health AG

c/o evalueSCIENCE

Entity Type: 25

Trademark Details

Filing Date

September 29, 2020

Registration Date

Not Registered

Goods & Services

Training; provision of online publications and online seminars; coaching; all services in this class in the field of medicine and support and advice for patients and health professionals

Computer programs for use in data networks to assist patients and doctors concerning the treatment of illnesses; application software in the medical field, in particular in the fields of patient support and consultation; application software for the capture of medical data on patients for the purposes of remote monitoring of patients and coordination of their care; application software for data entry, data processing and reporting for medical purposes; downloadable and non-downloadable software for data entry, data processing and the exchange of data and patient information, including the results of patient reports and assessments of clinical treatment outcomes by computer, in particular in the field of oncology

Transmission of information via electronic communication networks; transmission of information, in particular information for the purposes of medical advice and care; provision of access to databases; provision of access to databases in the medical field; provision of access to Internet platforms in the medical field

Input of information on the use of pharmaceuticals and other medical treatments

Medical services, in particular medical advice and care, provided by means of application software and the Internet; observation of patients; advice and information services concerning pharmaceuticals and other forms of medical treatment, provided by means of application software and the Internet; preparation of medical health reports; all services in this class in the field of medicine and support and advice for patients and medical staff

Scientific and medical research; provision of application software for the capture of medical data on patients for the purposes of remote patient monitoring and healthcare coordination using data processing devices, web-based computers, SMS (short message services) and mobile devices; provision of software as a service [SaaS]; all services in this category in the field of medicine and support and advice for patients and medical staff

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 13, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Sep 20, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 20, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 30, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 11, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 11, 2022 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2022 NREP
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 20, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 20, 2021 ABN2
NEW REPRESENTATIVE AT IB RECEIVED
Aug 20, 2021 NREP
REFUSAL PROCESSED BY IB
Mar 28, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 8, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 3, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 2, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 23, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 15, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 10, 2020 REPR